The drug industry is doomed

[Guest guest]

Dear group:

The many big lies of big pharma are finally being

brought to the light of day. As a result of this, the

drug industry is currently fighting for its very

survival.

What follows is a rather remarkable letter from Dr.

Mathias Rath. According to Dr. Rath the entire class

of medications to lower cholesterol is in the process

of collapsing.(This letter can be found on

http://www.drrathhealthalliance.com/news/letter_from_Dr_Rath.php)

I cannot thank Dr. Rath enough for writing and

circulating this material, as well as for all of his

efforts over the years in regard to fighting the many

evils of big pharma.

Couple Dr. Raths's information with the fact that what

I have learned about how to treat depression properly

(as delineated in various blogs on

http:///360./allen_dar) threatens the entire

class of antidepressant medications, the result is

that the drug industry is in far more trouble than

most people realize.

It is my sincere belief that the drug industry as we

know it today is doomed. It is only a matter of time.

Darman

A Direct Letter From Dr. Rath

January 22, 2008

Dear all,

Apparently not only the stock markets tumble, but also

the much acclaimed hypothesis that

cholesterol-lowering reduces heart attacks.

Or is there a hidden connection between the two? The

timing does not exclude it – nor do the issues at

stake.

With over $40 billion in annual sales, cholesterol

lowering drugs are the single largest element in the

pharmaceutical business portfolio.

If the connection between cholesterol-lowering and

prevention of cardiovascular disease breaks, this

market is doomed and with it the credibility of the

pharmaceutical investment business in many other

areas.

And precisely that is the Mene-tekel written in big

letters on the wall for the drug industry:

On January 15, 16 and 17, the New York Times (click on

dates to view attachments) reported about another

major scandal of the drug industry. Merck and Schering

had tested their cholesterol-lowering drugs in a large

trial designed to establish the connection between

cholesterol lowering and the prevention of heart

disease.

The results of this much anticipated study were

" shocking. " As reported in the New York Times, the

coronary artery plaques - the basis of a heart attack

- developed twice as fast in those people taking the

cholesterol-lowering drugs! To make things worse,

Merck and Schering had been sitting on these

explosives data for almost two years – while about 5

million people worldwide continued to take this drug.

US Congress has launched a Congressional

investigations and the New York Times is publicly

demanding a new law prohibiting such abuse.

But the real problem here goes much deeper. The global

fraud of the drug industry with the world's three

largest health markets is now complete and open for

everyone to see:

1. They promote chemotherapy against *cancer* without

any evidence for cure. To the contrary, the most

common side effects of chemotherapy its new cancer

–and new drug market opportunities.

2. They promote ARV drugs against* immune

deficiencies* without any evidence for cure. To the

contrary, ARVs further damage the immune system,

thereby paving the way for new infections - and new

drug market opportunities.

3. Now there is proof that the biggest health problems

of our time, *cardiovascular disease*, has been also

used as a market opportunity by the pharmaceutical

industry - at the expense of the health and lives of

millions of people. For more than two decades, they

have been promoting cholesterol-lowering statins by

creating the fraudulent perception that it prevents

heart attacks. Now this perception too has been

exposed as a marketing Fata a – and a fraud on

the public in the range of trillions of dollars

(including the follow-up costs).

Yesterday, Merck and Schering had to place a two page

advertisement in the " USA Today, " the world's largest

newspaper (see attachment). While trying to put the

finger in the breaking damn, they may have made things

worse. It is highly significant that nowhere in this

`damage control' advertisement are these drug

companies stating that there is any proof that

cholesterol-lowering drugs reduce the risk of heart

disease. If any such proof existed, this would have

been the moment to play that card. But they could not

play it because it does not exist! In light of that

fact the statement that the American Heart Association

also thinks that cholesterol-lowering is " important "

is nothing less than a declaration of bankruptcy for

the cholesterol-heart disease hypothesis.

This fact is highly reminiscent of the ARV business,

where even the product information sheets for ARV

drugs specify that this drug is no cure for HIV and

AIDS and even specifies that its side effects include

immune deficiencies.

It is obvious that this industry has only been able to

survive this giant of fraud by sponsoring their

lobbyists in politics, the health profession, the

media - and even in the streets, like the South

African TAC drug-pushers.

*The drug industry is no longer fighting for the

survival of individual drug markets. It is now

fighting for the credibility of this industry in

general.*

This insight may not be limited to the drug companies

alone, but may have already spilled over to some

farsighted analysts and investors. While the US

mortgage market is being officially blamed for this

crisis, there may be other – even more important -

reasons.

I am expressing my hope, that this credibility crisis

and agony of the pharmaceutical industry – the world's

second largest investment business - will not be

" solved " like other crises before that threatened the

global financial system – i.e. by starting a war.

Unfortunately, today's lead story in the British

Guardian, does not necessarily feed this hope

(Attachment).

I am convinced, however, that our work – including the

various litigations - is instrumental in helping to

establish the truth and overcoming this impasse.

Regards,

Dr. Rath

Editor's Note - In respect to the public release of

this study and the question regarding why the lowering

of cholesterol did not lead to the decrease in plaque

formation, Dr. Niedzwiecki wrote letters to the

editors of the New York Times, Business Week, Whole

Foods, and USA Today, a copy of which is here.

________________________________________________________________________________\

____

Never miss a thing. Make your home page.

http://www./r/hs